The global head and neck cancer drugs market size is
expected to be valued at USD 1.41 billion by 2022, as per a new report by Grand
View Research, Inc., registering a CAGR of 9.4% during the forecast period. The
market is expected to be collectively driven by development of innovative and
cost-effective treatments, numerous side effects related to radiation therapy
and chemotherapy, increased healthcare expenditure, and better government
initiatives.
As most patients suffering from head and neck cancer are diagnosed at an
advanced stage, their management is often done with a multidisciplinary
approach involving surgery, radiation therapy, chemotherapy, and immunotherapy
in the head and neck cancer therapeutics market. Major challenges faced by this
patient population are morbidity issues and poor quality of life owing to the
incapacitating effects of standard of care treatment paradigms. Anemia,
diarrhea, nausea, vomiting, joint pain, and osteoporosis are some of the main
side effects resulting from head and neck cancer treatments.
Based on recent clinical results, immunotherapies have gained traction
as a precision medicine initiative for the management of head and neck cancer.
Increased immunity and immune modulation research in cancer offers new
vulnerabilities that may be pharmacologically exploitable. Immunotherapy drugs
such as PD inhibitors, Opdivo, and Keytruda have shown superior safety and
efficacy profile in treatment of head and neck cancer. Expansion of
immunotherapies will continue moving toward rational combinations with other
first line or adjuvant therapies for effective treatment of metastatic or
recurrent head and neck cancer. EGFR and microtubule inhibitor therapeutic
classes are witnessing a fundamental shift from biologics to biosimilars.
Full research report on keyword
analysis:
https://www.grandviewresearch.com/industry-analysis/head-neck-cancer-drugs-therapeutics-market
https://www.grandviewresearch.com/industry-analysis/head-neck-cancer-drugs-therapeutics-market
Further key findings from the report suggest:
·
Market growth will be driven by rising
number of patients, increasing adoption of immunotherapeutic drugs, and launch
of new drug delivery approaches to improve overall survival rates
·
Among EU5, Germany captured the top
position in the global head and neck cancer therapeutics market, whereas by
2022, Spain is expected to lead the market. U.S. is expected to witness the
fastest growth over the forecast period
·
Immune checkpoint inhibitors such as Opdivo
and Keytruda are gaining traction and will continue to do so through forecast
period, capturing more than 60.0% of the market in 2022
·
PD inhibitors will capture market share
from microtubule inhibitors and EGFR inhibitors but will help expand overall
franchise revenue
·
Newer immunotherapies directed against PD-1
ligands and PD-L1 proteins have shown to be more effective with superior safety
profile
·
Late stage pipeline products include
checkpoint inhibitors such as Imfinzi and Bavencio
·
Key players operating in this industry
include Bristol-Myers Squibb, Merck, Eli Lilly, and Sanofi.
View more reports
of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global head and neck cancer drugs
market based on therapeutic class and region:
Head and Neck
Cancer Drugs Therapeutic Class Outlook (Revenue, USD Million, 2016 - 2022)
·
PD Inhibitors
·
EGFR Inhibitors
·
Microtubule Inhibitors
Head and Neck
Cancer Drugs Regional Outlook (Revenue, USD Million, 2016 - 2022)
·
U.S.
·
U.K.
·
France
·
Germany
·
Italy
·
Spain
·
Japan
Access Full Press
Release of this Report:
https://www.grandviewresearch.com/press-release/global-head-neck-cancer-drugs-therapeutics-market
https://www.grandviewresearch.com/press-release/global-head-neck-cancer-drugs-therapeutics-market
About Grand View Research
Grand View
Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
